The document discusses HLA typing methods. It describes the major histocompatibility complex (MHC) which contains the human leukocyte antigen (HLA) genes. HLA typing is important for transplant matching. Methods include serology using lymphocyte cytotoxicity, as well as molecular techniques like PCR with sequence-specific primers or probes and sequence-based typing for highest resolution. Each method has advantages and limitations in resolution and reliance on viable cells. Combining methods can resolve discrepancies.
Immunohistochemistry (IHC) is a highly sensitive method that allows the localization of antigen within a cell or a tissue with high resolution. The method is based on the use of a primary antibody that specifically binds to its complementary antigen. The bound antibody may then be visualized by a variety of methods such as colorimetric end points.
Hybridoma Technology ( Production , Purification , and Application ) Sakshi Ghasle
Hybridoma technology revolutionized the field of immunology by enabling the production of monoclonal antibodies with high specificity and affinity. This presentation delves into the principles of DNA hybridoma technology, highlighting its significance in antibody production, therapeutic applications, and biomedical research. Learn about the key steps involved in generating hybridomas, from immunization to antibody screening, and discover the potential of recombinant DNA techniques in enhancing antibody engineering. Whether you're a student, researcher, or industry professional, this overview will provide valuable insights into the innovative world of hybridoma technology."
Uncover the wide-ranging applications of monoclonal antibodies in areas such as cancer therapy, autoimmune diseases, infectious diseases, and beyond. Learn about the latest advancements in antibody engineering and the development of novel therapeutic modalities, including bispecific antibodies, antibody-drug conjugates, and immune checkpoint inhibitors.
Whether you're a seasoned researcher or a newcomer to the field, this SlideShare presentation serves as a valuable resource for understanding the principles, techniques, and applications of hybridoma technology in modern biomedicine. Join a journey through the fascinating world of monoclonal antibodies and the groundbreaking science behind their creation.
Unlock the potential of hybridoma technology and propel your research to new heights. Dive into this SlideShare presentation now and explore the limitless possibilities of monoclonal antibody production with hybridoma technology.
Immunohistochemistry (IHC) is a highly sensitive method that allows the localization of antigen within a cell or a tissue with high resolution. The method is based on the use of a primary antibody that specifically binds to its complementary antigen. The bound antibody may then be visualized by a variety of methods such as colorimetric end points.
Hybridoma Technology ( Production , Purification , and Application ) Sakshi Ghasle
Hybridoma technology revolutionized the field of immunology by enabling the production of monoclonal antibodies with high specificity and affinity. This presentation delves into the principles of DNA hybridoma technology, highlighting its significance in antibody production, therapeutic applications, and biomedical research. Learn about the key steps involved in generating hybridomas, from immunization to antibody screening, and discover the potential of recombinant DNA techniques in enhancing antibody engineering. Whether you're a student, researcher, or industry professional, this overview will provide valuable insights into the innovative world of hybridoma technology."
Uncover the wide-ranging applications of monoclonal antibodies in areas such as cancer therapy, autoimmune diseases, infectious diseases, and beyond. Learn about the latest advancements in antibody engineering and the development of novel therapeutic modalities, including bispecific antibodies, antibody-drug conjugates, and immune checkpoint inhibitors.
Whether you're a seasoned researcher or a newcomer to the field, this SlideShare presentation serves as a valuable resource for understanding the principles, techniques, and applications of hybridoma technology in modern biomedicine. Join a journey through the fascinating world of monoclonal antibodies and the groundbreaking science behind their creation.
Unlock the potential of hybridoma technology and propel your research to new heights. Dive into this SlideShare presentation now and explore the limitless possibilities of monoclonal antibody production with hybridoma technology.
Genetic engineering principle, tools, techniques, types and applicationTarun Kapoor
Basic principles of genetic engineering.
Study of cloning vectors, restriction endonucleases and DNA ligase.
Recombinant DNA technology. Application of genetic engineering in medicine.
Application of r DNA technology and genetic engineering in the products:
a. Interferon
b. Vaccines- hepatitis- B
c. Hormones- Insulin.
Polymerase chain reaction
Brief introduction to PCR
Basic principles of PCR
This pdf is about the Schizophrenia.
For more details visit on YouTube; @SELF-EXPLANATORY;
https://www.youtube.com/channel/UCAiarMZDNhe1A3Rnpr_WkzA/videos
Thanks...!
Slide 1: Title Slide
Extrachromosomal Inheritance
Slide 2: Introduction to Extrachromosomal Inheritance
Definition: Extrachromosomal inheritance refers to the transmission of genetic material that is not found within the nucleus.
Key Components: Involves genes located in mitochondria, chloroplasts, and plasmids.
Slide 3: Mitochondrial Inheritance
Mitochondria: Organelles responsible for energy production.
Mitochondrial DNA (mtDNA): Circular DNA molecule found in mitochondria.
Inheritance Pattern: Maternally inherited, meaning it is passed from mothers to all their offspring.
Diseases: Examples include Leber’s hereditary optic neuropathy (LHON) and mitochondrial myopathy.
Slide 4: Chloroplast Inheritance
Chloroplasts: Organelles responsible for photosynthesis in plants.
Chloroplast DNA (cpDNA): Circular DNA molecule found in chloroplasts.
Inheritance Pattern: Often maternally inherited in most plants, but can vary in some species.
Examples: Variegation in plants, where leaf color patterns are determined by chloroplast DNA.
Slide 5: Plasmid Inheritance
Plasmids: Small, circular DNA molecules found in bacteria and some eukaryotes.
Features: Can carry antibiotic resistance genes and can be transferred between cells through processes like conjugation.
Significance: Important in biotechnology for gene cloning and genetic engineering.
Slide 6: Mechanisms of Extrachromosomal Inheritance
Non-Mendelian Patterns: Do not follow Mendel’s laws of inheritance.
Cytoplasmic Segregation: During cell division, organelles like mitochondria and chloroplasts are randomly distributed to daughter cells.
Heteroplasmy: Presence of more than one type of organellar genome within a cell, leading to variation in expression.
Slide 7: Examples of Extrachromosomal Inheritance
Four O’clock Plant (Mirabilis jalapa): Shows variegated leaves due to different cpDNA in leaf cells.
Petite Mutants in Yeast: Result from mutations in mitochondrial DNA affecting respiration.
Slide 8: Importance of Extrachromosomal Inheritance
Evolution: Provides insight into the evolution of eukaryotic cells.
Medicine: Understanding mitochondrial inheritance helps in diagnosing and treating mitochondrial diseases.
Agriculture: Chloroplast inheritance can be used in plant breeding and genetic modification.
Slide 9: Recent Research and Advances
Gene Editing: Techniques like CRISPR-Cas9 are being used to edit mitochondrial and chloroplast DNA.
Therapies: Development of mitochondrial replacement therapy (MRT) for preventing mitochondrial diseases.
Slide 10: Conclusion
Summary: Extrachromosomal inheritance involves the transmission of genetic material outside the nucleus and plays a crucial role in genetics, medicine, and biotechnology.
Future Directions: Continued research and technological advancements hold promise for new treatments and applications.
Slide 11: Questions and Discussion
Invite Audience: Open the floor for any questions or further discussion on the topic.
Introduction:
RNA interference (RNAi) or Post-Transcriptional Gene Silencing (PTGS) is an important biological process for modulating eukaryotic gene expression.
It is highly conserved process of posttranscriptional gene silencing by which double stranded RNA (dsRNA) causes sequence-specific degradation of mRNA sequences.
dsRNA-induced gene silencing (RNAi) is reported in a wide range of eukaryotes ranging from worms, insects, mammals and plants.
This process mediates resistance to both endogenous parasitic and exogenous pathogenic nucleic acids, and regulates the expression of protein-coding genes.
What are small ncRNAs?
micro RNA (miRNA)
short interfering RNA (siRNA)
Properties of small non-coding RNA:
Involved in silencing mRNA transcripts.
Called “small” because they are usually only about 21-24 nucleotides long.
Synthesized by first cutting up longer precursor sequences (like the 61nt one that Lee discovered).
Silence an mRNA by base pairing with some sequence on the mRNA.
Discovery of siRNA?
The first small RNA:
In 1993 Rosalind Lee (Victor Ambros lab) was studying a non- coding gene in C. elegans, lin-4, that was involved in silencing of another gene, lin-14, at the appropriate time in the
development of the worm C. elegans.
Two small transcripts of lin-4 (22nt and 61nt) were found to be complementary to a sequence in the 3' UTR of lin-14.
Because lin-4 encoded no protein, she deduced that it must be these transcripts that are causing the silencing by RNA-RNA interactions.
Types of RNAi ( non coding RNA)
MiRNA
Length (23-25 nt)
Trans acting
Binds with target MRNA in mismatch
Translation inhibition
Si RNA
Length 21 nt.
Cis acting
Bind with target Mrna in perfect complementary sequence
Piwi-RNA
Length ; 25 to 36 nt.
Expressed in Germ Cells
Regulates trnasposomes activity
MECHANISM OF RNAI:
First the double-stranded RNA teams up with a protein complex named Dicer, which cuts the long RNA into short pieces.
Then another protein complex called RISC (RNA-induced silencing complex) discards one of the two RNA strands.
The RISC-docked, single-stranded RNA then pairs with the homologous mRNA and destroys it.
THE RISC COMPLEX:
RISC is large(>500kD) RNA multi- protein Binding complex which triggers MRNA degradation in response to MRNA
Unwinding of double stranded Si RNA by ATP independent Helicase
Active component of RISC is Ago proteins( ENDONUCLEASE) which cleave target MRNA.
DICER: endonuclease (RNase Family III)
Argonaute: Central Component of the RNA-Induced Silencing Complex (RISC)
One strand of the dsRNA produced by Dicer is retained in the RISC complex in association with Argonaute
ARGONAUTE PROTEIN :
1.PAZ(PIWI/Argonaute/ Zwille)- Recognition of target MRNA
2.PIWI (p-element induced wimpy Testis)- breaks Phosphodiester bond of mRNA.)RNAse H activity.
MiRNA:
The Double-stranded RNAs are naturally produced in eukaryotic cells during development, and they have a key role in regulating gene expression .
Multi-source connectivity as the driver of solar wind variability in the heli...Sérgio Sacani
The ambient solar wind that flls the heliosphere originates from multiple
sources in the solar corona and is highly structured. It is often described
as high-speed, relatively homogeneous, plasma streams from coronal
holes and slow-speed, highly variable, streams whose source regions are
under debate. A key goal of ESA/NASA’s Solar Orbiter mission is to identify
solar wind sources and understand what drives the complexity seen in the
heliosphere. By combining magnetic feld modelling and spectroscopic
techniques with high-resolution observations and measurements, we show
that the solar wind variability detected in situ by Solar Orbiter in March
2022 is driven by spatio-temporal changes in the magnetic connectivity to
multiple sources in the solar atmosphere. The magnetic feld footpoints
connected to the spacecraft moved from the boundaries of a coronal hole
to one active region (12961) and then across to another region (12957). This
is refected in the in situ measurements, which show the transition from fast
to highly Alfvénic then to slow solar wind that is disrupted by the arrival of
a coronal mass ejection. Our results describe solar wind variability at 0.5 au
but are applicable to near-Earth observatories.
Earliest Galaxies in the JADES Origins Field: Luminosity Function and Cosmic ...Sérgio Sacani
We characterize the earliest galaxy population in the JADES Origins Field (JOF), the deepest
imaging field observed with JWST. We make use of the ancillary Hubble optical images (5 filters
spanning 0.4−0.9µm) and novel JWST images with 14 filters spanning 0.8−5µm, including 7 mediumband filters, and reaching total exposure times of up to 46 hours per filter. We combine all our data
at > 2.3µm to construct an ultradeep image, reaching as deep as ≈ 31.4 AB mag in the stack and
30.3-31.0 AB mag (5σ, r = 0.1” circular aperture) in individual filters. We measure photometric
redshifts and use robust selection criteria to identify a sample of eight galaxy candidates at redshifts
z = 11.5 − 15. These objects show compact half-light radii of R1/2 ∼ 50 − 200pc, stellar masses of
M⋆ ∼ 107−108M⊙, and star-formation rates of SFR ∼ 0.1−1 M⊙ yr−1
. Our search finds no candidates
at 15 < z < 20, placing upper limits at these redshifts. We develop a forward modeling approach to
infer the properties of the evolving luminosity function without binning in redshift or luminosity that
marginalizes over the photometric redshift uncertainty of our candidate galaxies and incorporates the
impact of non-detections. We find a z = 12 luminosity function in good agreement with prior results,
and that the luminosity function normalization and UV luminosity density decline by a factor of ∼ 2.5
from z = 12 to z = 14. We discuss the possible implications of our results in the context of theoretical
models for evolution of the dark matter halo mass function.
Deep Behavioral Phenotyping in Systems Neuroscience for Functional Atlasing a...Ana Luísa Pinho
Functional Magnetic Resonance Imaging (fMRI) provides means to characterize brain activations in response to behavior. However, cognitive neuroscience has been limited to group-level effects referring to the performance of specific tasks. To obtain the functional profile of elementary cognitive mechanisms, the combination of brain responses to many tasks is required. Yet, to date, both structural atlases and parcellation-based activations do not fully account for cognitive function and still present several limitations. Further, they do not adapt overall to individual characteristics. In this talk, I will give an account of deep-behavioral phenotyping strategies, namely data-driven methods in large task-fMRI datasets, to optimize functional brain-data collection and improve inference of effects-of-interest related to mental processes. Key to this approach is the employment of fast multi-functional paradigms rich on features that can be well parametrized and, consequently, facilitate the creation of psycho-physiological constructs to be modelled with imaging data. Particular emphasis will be given to music stimuli when studying high-order cognitive mechanisms, due to their ecological nature and quality to enable complex behavior compounded by discrete entities. I will also discuss how deep-behavioral phenotyping and individualized models applied to neuroimaging data can better account for the subject-specific organization of domain-general cognitive systems in the human brain. Finally, the accumulation of functional brain signatures brings the possibility to clarify relationships among tasks and create a univocal link between brain systems and mental functions through: (1) the development of ontologies proposing an organization of cognitive processes; and (2) brain-network taxonomies describing functional specialization. To this end, tools to improve commensurability in cognitive science are necessary, such as public repositories, ontology-based platforms and automated meta-analysis tools. I will thus discuss some brain-atlasing resources currently under development, and their applicability in cognitive as well as clinical neuroscience.
This presentation explores a brief idea about the structural and functional attributes of nucleotides, the structure and function of genetic materials along with the impact of UV rays and pH upon them.
Observation of Io’s Resurfacing via Plume Deposition Using Ground-based Adapt...Sérgio Sacani
Since volcanic activity was first discovered on Io from Voyager images in 1979, changes
on Io’s surface have been monitored from both spacecraft and ground-based telescopes.
Here, we present the highest spatial resolution images of Io ever obtained from a groundbased telescope. These images, acquired by the SHARK-VIS instrument on the Large
Binocular Telescope, show evidence of a major resurfacing event on Io’s trailing hemisphere. When compared to the most recent spacecraft images, the SHARK-VIS images
show that a plume deposit from a powerful eruption at Pillan Patera has covered part
of the long-lived Pele plume deposit. Although this type of resurfacing event may be common on Io, few have been detected due to the rarity of spacecraft visits and the previously low spatial resolution available from Earth-based telescopes. The SHARK-VIS instrument ushers in a new era of high resolution imaging of Io’s surface using adaptive
optics at visible wavelengths.
2. The Major Histocompatability Complex
(MHC)
• The MHC is located on chromosome 6.
• The MHC contains the human leukocyte antigen (HLA)
and other genes.
1 Mb 2 Mb 3 Mb 4 Mb
HLA- DP DQ DR B C A
Class II Class III Class I
b a b a b a b b b b a a b
TNF
3. Genes of the Major Histocompatibility Locus
MHC region
Gene products Tissue location Function
Class I HLA-A, HLA-B, HLA-C All nucleated cells
Identification and
destruction of abnormal
or infected cells by
cytotoxic T cells
Class II HLA-D
B lymphocytes,
monocytes,
macrophages, dendritic
cells, activated T cells,
activated endothelial
cells, skin (Langerhans
cells)
Identification of foreign
antigen by helper T cells
Class III Complement C2, C4, B Plasma proteins
Defense against
extracellular pathogens
Cytokine
genes
TNFa, TNFb Plasma proteins
Cell growth and
differentiation
4. The Human Leukocyte Antigens (HLA)
Human leukocyte antigens, the MHC gene products, are
membrane proteins that are responsible for rejection of
transplanted organs and tissues.
b 2microglobulin
a 1 b1
a 2 b2
a 2 a1
a 3
HLA-D
Cell membrane
a chain b chain a chain
5. The Human Leukocyte Antigens (HLA)
• HLA-gene sequences differ from one individual to
another.
• Also written as:
• Each sequence is a different allele.
CGG GCC GCG GTG GAC ACC TAC TGC AGA CAC AAC TAC GGG GTT GGT GAG AGC TTC ACA
CGG GCC GCC GTG GAC ACC TAT TGC AGA CAC AAC TAC GGG GCT GTG GAG AGC TTC ACA
CGG GCC GCC GTG GAC ACC TAT TGC AGA CAC AAC TAC GGG GCT GTG GNN NNN NNN NNN
CGG GCC GCG GTG GAC ACC TAC TGC AGA CAC AAC TAC GGG GTT GGT GAG AGC TTC ACA
--- --- --- --- --- --- --T --- --- --- --- --- --- -C - -TG --- --- --- ---
--- --- --C --- --- --- --T --- --- --- --- --- --- -C- -TG -** *** *** ***
a.
b.
6. HLA Allele Nomenclature
• A standard nomenclature has been established by the
World Health Organization (WHO) Nomenclature
Committee.
• A small “w” is included in HLA-C, HLAB-4, and HLAB-6
allele nomenclature: HLA-Cw, HLABw-4, HLABw-6.
HLA-DRB1
Gene region
Gene locus
Subregion
a- or b-chain polypeptide
7. HLA Allele Nomenclature
• HLA-typing at the DNA level requires nomenclature for
specific DNA sequences.
• Hundreds of HLA alleles identified so far in all loci.
HLA-DRB1*2503
Gene region
Gene locus
Subregion
a-or b-chain polypeptide
Allele family 25
Third allele
9. HLA-Typing
• Every person (except identical twins) has different
sets of HLA alleles.
• Transplanted organs are allografts, in which the
donor organ and the recipient are genetically
different.
• Compatibility (matching) of the HLA of the donor
and the recipient increases the chance for a
successful engraftment.
• Matching is determined by comparing alleles.
• Resolution is the level of detail with which an allele
is determined.
10. TYPING METHODS
• SEROLOGY used to be the ‘gold’
standard. Now being superseded by
molecular techniques as they
become more robust and time
efficient.
•
CELLULAR rarely used now. Originally
used for Class II typing.
• MOLECULAR fast becoming the method of
choice.
11. SEROLOGY
• Complement Dependent Cytotoxicity
(CDC)
• Viable peripheral blood lymphocytes
are obtained by discontinuous density
gradient centrifugation using Ficoll /
Tryosil or Ficoll / Sodium Metrizoate at
a density of 1.077 at 19º - 22ºC.
• Microlymphocytotoxic test: 3 stages
12. Microlymphocytotoxic test
• 1.Viable lymphocytes are incubated
with HLA specific antibodies. If the
specific antigen is present on the
cell the antibody is bound.
• 2.Rabbit serum as a source of
complement is added, incubate. If
antibody is bound to the HLA antigen
on the cell surface it activates the
complement which damages the cell
membrane making it permeable to
vital stains.
13. Microlymphocytotoxic test Contd….
• 3.Results are visualised by adding dye
usually a fluorochrome eg Ethidium
Bromide although both Trypan Blue and
Eosin have been used in the past.
• If the reaction has taken place the EB
enters the cell and binds to the DNA.
• For ease double staining is normally used.
We use a cocktail of Ethidium Bromide and
Acridine Orange, quenched using Bovine
Haemoglobin to allow simultaneous
visualisation of both living and dead cells.
14. Microlymphocytotoxic test Contd….
• Test is left for 10 minutes and then read
using an inverted fluorescent microscope.
• A mixture of T and B lymphocytes can be
used for HLA Class I typing.
• B lymphocytes are required for HLA Class II
typing by serology. (Normal population 85-
90% T and 10-15% B cells)
• This can be achieved using a number of
methods.
15. Microlymphocytotoxic test
Contd….
• In the past neuraminidase treated sheep red
blood cell rosetting and nylon wool have
been used.
• Immunomagnetic bead separation is the
current method of choice.
• It utilises polystyrene microspheres with a
magnetisable core coated in monoclonal
antibody for a HLA Class II b chain
monomorphic epitope. Positive selection.
16. Serological Typing
Lymphocytes are HLA-typed by crossmatching to panel
reactive antibodies (PRA) using the complement-
dependent cytotoxicity (CDC) test.
Complement
antibody
Negative reaction to antibody:
cells survive and exclude dye.
Buffy coat
from patient
Positive reaction to antibody
kills cells. Dead cells pick up dye.
17. Serological Typing
Recipient antihuman antibodies are assessed by
crossmatching to donor lymphocytes.
Recipient serum
Lymphocytes from organ
donor or lymphocytes of
known HLA types
Positive reaction to antibody
kills cells. Dead cells pick up dye.
Negative reaction to antibody:
cells survive and exclude dye.
18. Serological Typing Using Bead Arrays
Recipient antihuman antibodies are assessed by
crossmatching to known lymphocyte antigens conjugated
to microparticles. Results are assessed by flow cytometry.
Positive for antibody
Serum
antibodies
(Wash)
Negative for antibody
Beads
conjugated to
different
lymphocyte
antigens
Fluorescent
reporter
antibodies
19. Other Serological Typing
Methods
• Cytotoxic and noncytotoxic methods with flow
cytometry detection.
• Enzyme-linked immunosorbent assay (ELISA) with
solubilized HLA antigens.
• Mixed lymphocyte culture measuring growth of
lymphocytes activated by cross-reactivity.
• Measure of HLA-protein mobility differences in one-
dimensional gel isoelectric focusing or two-
dimensional gel electrophoresis.
20. Pros and cons
• Pros:
• Easily performed does not require expensive
equipment.
• Takes around three hours to perform
• Low level resolution, with good antisera reliable
results
• Cons:
• Requires large volumes of blood
• Requires viable lymphocytes
• Difficult to find good antisera for rarer antigens in
different populations
21. Cellular typing
• Not / Rarely used by laboratories
these days.
• Requires panels of homozygous
typing cells.
• Cell culture method therefore takes
a long time. Labour intensive
involves use of radioisotopes.
22. Molecular typing
• All commonly used molecular methods
require good quality genomic DNA. There
are numerous methods for extraction of
DNA from whole blood.
• There are ‘in house’ methods based on
Miller et al’s Salting Out which are cheap
and easy but labour intensive.
• There are also numerous commercial kits
available such as individual matrix capture
columns, beads and semi automated
systems. This however can increase the
cost per extraction from around 65p to
£3.60p.
23. Molecular typing Contd…….
• All methods rely on DNA extraction from the
nucleated cells following cell lysis and
protein digestion.
• The application of molecular techniques to
HLA typing began around 1987 when the
Southern Blot technique was used to
identify restriction fragment length
polymorphisms (RFLP’s) associated with
known serological DR/DQ and cellular Dw
defined specificities.
• Around 1992 polymerase chain reaction
(PCR) methods were developed.
24. Molecular typing Contd…….
• PCR
• Three steps per cycle–
denaturation, annealing and
extension. Amplification is
exponential yielding 2 power n
where n = number of cycles.
• The introduction of the
programmable Thermal Cycler
revolutionised the use of PCR
within the routine laboratory.
25. Molecular typing Contd…….
• PCT SSP (Sequence Specific Priming)
• Can be used for HLA Class I and II typing
using a panel of primer pairs either for low
to medium resolution whereby primers
amplify groups of alleles or high resolution
whereby primer pairs amplify specific
alleles. Each PCR reaction takes place in a
separate tube therefore the number of
tubes depends on the level of resolution.
Each tube also contains a pair of primers
for part of the human growth hormone gene
as an internal control. These are at a much
lower concentration thus do not compete
with specific primers.
26. Molecular typing Contd…….
• Electrophoresis is used following
amplification. PCR product is run out on an
agarose gel containing ethidium bromide.
Each product moves according to its size
and is compared to a molecular weight
marker.
• Interpretation: every tube should produce
an identical sized product as internal
control and either a specific band or not
dependent on whether the allele(s) is/are
present or not.
• Results are visualised using 312nm UV
transillumination and recorded either by
video imaging or polaroid photography.
27. Molecular typing Contd…….
• PCR SSOP ( Sequence Specific
Oligonucleotide Probes).
• ‘Dot blot’ in house method usually whereby
one labels ones own probes with
Digoxigenin.
• ‘Reverse dot blot’ normally commercial
where specific oligonucleotide probes are
attached to a nylon membrane. Dynal and
Innotrans for example produce such kits.
28. Molecular typing Contd…….
• Amplification: DNA of interest is amplified by
a single pair of biotinylated primers which
flank the whole of exon eg exon 2 of the HLA
DRB1 gene. PCR amplifies all the alleles in
the exon.
• Hybridisation: PCR product is denatured and
then added to a ‘well’ containing the nylon
membrane with the bound probes and
incubated with hybridisation buffer . PCR
product hybridises to probes with
complementary sequences.
• Excess product is washed away during a
series of wash steps.
• Temperature is VERY important during these
stages.
29. Molecular typing Contd…….
• Visualisation of results is achieved by
incubating with a conjugate and enzyme
often streptavidin and horse radish
peroxidase which binds to the biotin of the
PCR product and then adding a substrate.
Band with PCR product turn blue.
• Strips will have internal control bands to
show the test has worked.
• Interpretation is usually achieved by entering
the band pattern into a computer
programme.
• This is an excellent method for low
resolution batch testing.
30. Molecular typing Contd…….
• Sequence Based Typing (SBT)
• DNA sequencing is the determination of
the sequence of a gene and thus is the
highest resolution possible. Sequence
based typing involves PCR amplification of
the gene of interest eg HLA DRB1 followed
by determination of the base sequence.
The sequence is then compared with a
database of DRB1 gene sequences to find
comparable sequences and assign alleles.
This method also allows for detection on
new alleles.
31. Molecular typing Contd…….
• Other molecular methods:
• Reference Strand Conformational Analysis
(RSCA) Offers sequence level typing
without the need to sequence. Assigns
HLA type on the basis of accurate
measurement of conformation i.e. shape
dependent on DNA mobility in
Polyacrylamide gel electrophoresis
(PAGE). Complex and difficult technique
not taken up by labs for routine use.
• Luminex technology – SSOP based. Just
beginning to be introduced into
laboratories for routine use on non urgent
samples.
32. DNA-Based Typing
Methods
• DNA typing focuses on the most polymorphic
loci in the MHC, HLA-B, and HLA-DRB.
• Whole-blood patient specimens collected in
anticoagulant are used for DNA typing.
• Cell lines of known HLA type are used for
reference samples.
33. DNA-Based Typing Methods: SSOP
Sequence-specific oligonucleotide probe
hybridization (SSOP, SSOPH)
TAG C GAT
ATC G CTA
TAG A GAT
ATC T CTA
Specimen 1 (Type A*0203) Specimen 2 Type A*0501
Amplify, denature, and
spot onto membranes
Specimen 1
Specime
n 2
Probe with allele-specific probes
...TAGCGAT..(A*02) ...TAGAGAT…(A*05)
Specimen 1 Specimen 2 Specimen 1 Specimen 2
34. DNA-Based Typing
Methods: SSP-PCR
Sequence-specific PCR is performed with
allele-specific primers.
SSP
Amplification
No
amplification
SSP
Amplification
controls
Allele-specific
product
SSP= Sequence-specific primer
SSP matches allele
SSP does not match allele
35. DNA-Based Typing Methods:
SSP-PCR
Primers recognizing different alleles are
supplied in a 96-well plate format.
Amplification control
Allele-specific product
Reagent blank
Agarose gel
36. DNA-Based Typing Methods: Sequence-
based Typing
• Sequence-based typing (SBT) is high
resolution.
• Polymorphic regions are amplified by PCR and
then sequenced.
Exon 2 Exon 3
HLA-B
Forward PCR primer
Sequencing primers
Reverse PCR primer
38. Pros and cons
•
•
•
•
•
Pros:
Does not require viable cells
Samples do not have to arrive in the lab the
day they are taken
PCR SSOP good for batch testing Can be
semi automated
•
•
•
•
Cons:
Requires good quality DNA
Require a degree of redundancy within the
primers used
Sequence of alleles must be known.
39. Typing Discrepancies
• DNA sequence changes do not always affect epitopes.
• Serology does not recognize every allele detectable by DNA.
• New antigens recognized by serology may be assigned to a
previously identified parent allele by SBT.
• Serology antibodies may be cross-reactive for multiple
alleles.
• Due to new allele discovery, retyping results may differ from
typing performed before the new allele was known.
41. Combining Typing Results
• SSP-PCR followed by PCR RFLP.
• SSOP followed by SSP-PCR.
• SBT results clarified by serology.
42. Summary
• The MHC is a polymorphic locus encoding the HLA genes.
• Antigens encoded by the HLA genes are responsible for
allograft tissue and organ rejection. Identifying and
matching alleles increases the chance of successful organ
and tissue transplant.
• HLA antigens and their corresponding sequence alleles are
determined by serological- and DNA- based methods.
• Serology identifies functional antigen recognition, while
sequence analysis identifies genetic alleles with high
resolution.